These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 24709425)

  • 41. WNT5A signaling impairs breast cancer cell migration and invasion via mechanisms independent of the epithelial-mesenchymal transition.
    Prasad CP; Chaurasiya SK; Guilmain W; Andersson T
    J Exp Clin Cancer Res; 2016 Sep; 35(1):144. PubMed ID: 27623766
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Quantitative Proteomics Reveals Knockdown of CD44 Promotes Proliferation and Migration in Claudin-Low MDA-MB-231 and Hs 578T Breast Cancer Cell Lines.
    Kim H; Woo J; Dan K; Lee KM; Jin MS; Park IA; Ryu HS; Han D
    J Proteome Res; 2021 Jul; 20(7):3720-3733. PubMed ID: 34075748
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A novel mouse model of human breast cancer stem-like cells with high CD44+CD24-/lower phenotype metastasis to human bone.
    Ling LJ; Wang S; Liu XA; Shen EC; Ding Q; Lu C; Xu J; Cao QH; Zhu HQ; Wang F
    Chin Med J (Engl); 2008 Oct; 121(20):1980-6. PubMed ID: 19080260
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Fish oil prevents breast cancer cell metastasis to bone.
    Mandal CC; Ghosh-Choudhury T; Yoneda T; Choudhury GG; Ghosh-Choudhury N
    Biochem Biophys Res Commun; 2010 Nov; 402(4):602-7. PubMed ID: 20971068
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of normothermic microwave irradiation on CD44
    Asano M; Tanaka S; Sakaguchi M
    Biosci Biotechnol Biochem; 2020 Jan; 84(1):103-110. PubMed ID: 31559912
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Paper-supported co-culture system for dynamic investigations of the lung-tropic migration of breast cancer cells.
    Lin D; Chen X; Lin Z; Lin J; Liu Y; Liu D
    Biomed Mater; 2021 Feb; 16(2):025028. PubMed ID: 33075760
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cluster of differentiation 44 promotes osteosarcoma progression in mice lacking the tumor suppressor Merlin.
    Ma J; Klemm J; Gerardo-Ramírez M; Frappart L; Castven D; Becker D; Zoch A; Parent R; Bartosch B; Minnich K; Giovannini M; Danckwardt S; Hartmann N; Morrison H; Herrlich P; Marquardt JU; Hartmann M
    Int J Cancer; 2020 Nov; 147(9):2564-2577. PubMed ID: 32525563
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CD44 interaction with tiam1 promotes Rac1 signaling and hyaluronic acid-mediated breast tumor cell migration.
    Bourguignon LY; Zhu H; Shao L; Chen YW
    J Biol Chem; 2000 Jan; 275(3):1829-38. PubMed ID: 10636882
    [TBL] [Abstract][Full Text] [Related]  

  • 49. WNT5A inhibits metastasis and alters splicing of Cd44 in breast cancer cells.
    Jiang W; Crossman DK; Mitchell EH; Sohn P; Crowley MR; Serra R
    PLoS One; 2013; 8(3):e58329. PubMed ID: 23484019
    [TBL] [Abstract][Full Text] [Related]  

  • 50. NF-κB affects proliferation and invasiveness of breast cancer cells by regulating CD44 expression.
    Smith SM; Lyu YL; Cai L
    PLoS One; 2014; 9(9):e106966. PubMed ID: 25184276
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Functional clustering of metastasis proteins describes plastic adaptation resources of breast-cancer cells to new microenvironments.
    Martín B; Sanz R; Aragüés R; Oliva B; Sierra A
    J Proteome Res; 2008 Aug; 7(8):3242-53. PubMed ID: 18582095
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification of the functional role of peroxiredoxin 6 in the progression of breast cancer.
    Chang XZ; Li DQ; Hou YF; Wu J; Lu JS; Di GH; Jin W; Ou ZL; Shen ZZ; Shao ZM
    Breast Cancer Res; 2007; 9(6):R76. PubMed ID: 17980029
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Overexpression of CD44 accompanies acquired tamoxifen resistance in MCF7 cells and augments their sensitivity to the stromal factors, heregulin and hyaluronan.
    Hiscox S; Baruha B; Smith C; Bellerby R; Goddard L; Jordan N; Poghosyan Z; Nicholson RI; Barrett-Lee P; Gee J
    BMC Cancer; 2012 Oct; 12():458. PubMed ID: 23039365
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inducible formation of leader cells driven by CD44 switching gives rise to collective invasion and metastases in luminal breast carcinomas.
    Yang C; Cao M; Liu Y; He Y; Du Y; Zhang G; Gao F
    Oncogene; 2019 Nov; 38(46):7113-7132. PubMed ID: 31417182
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Triple negative breast cancer initiating cell subsets differ in functional and molecular characteristics and in γ-secretase inhibitor drug responses.
    Azzam DJ; Zhao D; Sun J; Minn AJ; Ranganathan P; Drews-Elger K; Han X; Picon-Ruiz M; Gilbert CA; Wander SA; Capobianco AJ; El-Ashry D; Slingerland JM
    EMBO Mol Med; 2013 Oct; 5(10):1502-22. PubMed ID: 23982961
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Microenvironmental networks promote tumor heterogeneity and enrich for metastatic cancer stem-like cells in Luminal-A breast tumor cells.
    Weitzenfeld P; Meshel T; Ben-Baruch A
    Oncotarget; 2016 Dec; 7(49):81123-81143. PubMed ID: 27835603
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The thrombin inhibitor Argatroban reduces breast cancer malignancy and metastasis via osteopontin-dependent and osteopontin-independent mechanisms.
    Schulze EB; Hedley BD; Goodale D; Postenka CO; Al-Katib W; Tuck AB; Chambers AF; Allan AL
    Breast Cancer Res Treat; 2008 Nov; 112(2):243-54. PubMed ID: 18097747
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Radiation-induced lung damage promotes breast cancer lung-metastasis through CXCR4 signaling.
    Feys L; Descamps B; Vanhove C; Vral A; Veldeman L; Vermeulen S; De Wagter C; Bracke M; De Wever O
    Oncotarget; 2015 Sep; 6(29):26615-32. PubMed ID: 26396176
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Differential recruitment of CD44 isoforms by ErbB ligands reveals an involvement of CD44 in breast cancer.
    Morath I; Jung C; Lévêque R; Linfeng C; Toillon RA; Warth A; Orian-Rousseau V
    Oncogene; 2018 Mar; 37(11):1472-1484. PubMed ID: 29321661
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Osteopontin promotes CCL5-mesenchymal stromal cell-mediated breast cancer metastasis.
    Mi Z; Bhattacharya SD; Kim VM; Guo H; Talbot LJ; Kuo PC
    Carcinogenesis; 2011 Apr; 32(4):477-87. PubMed ID: 21252118
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.